Market Place
Sourcing Support
Takeda to stop making parathyroid drug Natpara after production challenges
05 Oct 2022 //
BIOPHARMADIVE
Takeda`s rare disease unit suffers on hemophilia, Natpara recall
01 Nov 2019 //
FIERCE PHARMA
Enforcement Report - Week of October 2, 2019
02 Oct 2019 //
FDA
Rhetoric or a real threat? Track your pharma politics here
16 Sep 2019 //
FIERCE PHARMA
Takeda recalls eye drug Natpara, warns patients not to abruptly stop treatment
07 Sep 2019 //
FIERCEPHARMA
Takeda Issues US Recall of NATPARA® (parathyroid hormone)
06 Sep 2019 //
FDA
Nps Pharms` Natpara(Parathyroid Hormone) Receives Approval in US
17 Dec 2018 //
FDA
Takeda Is Said to Weigh Sale of Shire Eye Drug to Cut Debt
14 Sep 2018 //
BLOOMBERG
Takeda weighs sale of Shire`s eye care business to cut debt- Bloomberg
13 Sep 2018 //
CNBC
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.